250 related articles for article (PubMed ID: 31496684)
1. Intravesical delivery of rapamycin via folate-modified liposomes dispersed in thermo-reversible hydrogel.
Yoon HY; Chang IH; Goo YT; Kim CH; Kang TH; Kim SY; Lee SJ; Song SH; Whang YM; Choi YW
Int J Nanomedicine; 2019; 14():6249-6268. PubMed ID: 31496684
[TBL] [Abstract][Full Text] [Related]
2. A floating hydrogel system capable of generating CO2 bubbles to diminish urinary obstruction after intravesical instillation.
Lin T; Zhang Y; Wu J; Zhao X; Lian H; Wang W; Guo H; Hu Y
Pharm Res; 2014 Oct; 31(10):2655-63. PubMed ID: 24752478
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine hydrochloride microspheres used for intravesical treatment of superficial bladder cancer: a comprehensive in vitro/ex vivo/in vivo evaluation.
Karavana SY; Şenyiğit ZA; Çalışkan Ç; Sevin G; Özdemir Dİ; Erzurumlu Y; Şen S; Baloğlu E
Drug Des Devel Ther; 2018; 12():1959-1975. PubMed ID: 29997433
[TBL] [Abstract][Full Text] [Related]
4. Folate receptor-targeted liposomes enhanced the antitumor potency of imatinib through the combination of active targeting and molecular targeting.
Ye P; Zhang W; Yang T; Lu Y; Lu M; Gai Y; Ma X; Xiang G
Int J Nanomedicine; 2014; 9():2167-78. PubMed ID: 24855354
[TBL] [Abstract][Full Text] [Related]
5. Externally Triggered Novel Rapid-Release Sonosensitive Folate-Modified Liposomes for Gemcitabine: Development and Characteristics.
Omar MM; Hasan OA; Zaki RM; Eleraky NE
Int J Nanomedicine; 2021; 16():683-700. PubMed ID: 33536754
[TBL] [Abstract][Full Text] [Related]
6. Delivery of Rapamycin by Liposomes Synergistically Enhances the Chemotherapy Effect of 5-Fluorouracil on Colorectal Cancer.
Chen YQ; Zhu WT; Lin CY; Yuan ZW; Li ZH; Yan PK
Int J Nanomedicine; 2021; 16():269-281. PubMed ID: 33469286
[TBL] [Abstract][Full Text] [Related]
7. Deformable Liposomal Hydrogel for Dermal and Transdermal Delivery of Meloxicam.
Zhang ZJ; Osmałek T; Michniak-Kohn B
Int J Nanomedicine; 2020; 15():9319-9335. PubMed ID: 33262590
[TBL] [Abstract][Full Text] [Related]
8. Folate-Mediated Targeted Delivery of Combination Chemotherapeutics Loaded Reduced Graphene Oxide for Synergistic Chemo-Photothermal Therapy of Cancers.
Thapa RK; Choi Y; Jeong JH; Youn YS; Choi HG; Yong CS; Kim JO
Pharm Res; 2016 Nov; 33(11):2815-27. PubMed ID: 27573575
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid on the urokinase sustained release with a hydrogel system composed of poloxamer 407: HA/P407 hydrogel system for drug delivery.
Hsieh HY; Lin WY; Lee AL; Li YC; Chen YJ; Chen KC; Young TH
PLoS One; 2020; 15(3):e0227784. PubMed ID: 32160196
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of antitumor effect of zoledronic acid entrapped in folate-linked liposome for targeting to tumor-associated macrophages.
Hattori Y; Yamashita J; Sakaida C; Kawano K; Yonemochi E
J Liposome Res; 2015; 25(2):131-40. PubMed ID: 25203609
[TBL] [Abstract][Full Text] [Related]
11. Baicalin loaded in folate-PEG modified liposomes for enhanced stability and tumor targeting.
Chen Y; Minh LV; Liu J; Angelov B; Drechsler M; Garamus VM; Willumeit-Römer R; Zou A
Colloids Surf B Biointerfaces; 2016 Apr; 140():74-82. PubMed ID: 26741267
[TBL] [Abstract][Full Text] [Related]
12. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
[TBL] [Abstract][Full Text] [Related]
13. Folate receptor-targeted fluorescent paramagnetic bimodal liposomes for tumor imaging.
Ding N; Lu Y; Lee RJ; Yang C; Huang L; Liu J; Xiang G
Int J Nanomedicine; 2011; 6():2513-20. PubMed ID: 22072885
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels.
He W; Guo X; Feng M; Mao N
Int J Pharm; 2013 Dec; 458(2):305-14. PubMed ID: 24409520
[TBL] [Abstract][Full Text] [Related]
15. Intravesical dual PI3K/mTOR complex 1/2 inhibitor NVP-BEZ235 therapy in an orthotopic bladder cancer model.
Matsushima M; Kikuchi E; Matsumoto K; Hattori S; Takeda T; Kosaka T; Miyajima A; Oya M
Int J Oncol; 2015 Jul; 47(1):377-83. PubMed ID: 25963317
[TBL] [Abstract][Full Text] [Related]
16. Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors.
Shmeeda H; Mak L; Tzemach D; Astrahan P; Tarshish M; Gabizon A
Mol Cancer Ther; 2006 Apr; 5(4):818-24. PubMed ID: 16648551
[TBL] [Abstract][Full Text] [Related]
17. Thermosensitive micelles-hydrogel hybrid system based on poloxamer 407 for localized delivery of paclitaxel.
Ju C; Sun J; Zi P; Jin X; Zhang C
J Pharm Sci; 2013 Aug; 102(8):2707-17. PubMed ID: 23839931
[TBL] [Abstract][Full Text] [Related]
18. Establishment of an orthotopic mouse non-muscle invasive bladder cancer model expressing the mammalian target of rapamycin signaling pathway.
Kim SJ; Seo HK; Seo HH; Lee SJ; Kwon JK; Lee TJ; Chi BH; Chang IH
J Korean Med Sci; 2014 Mar; 29(3):343-50. PubMed ID: 24616582
[TBL] [Abstract][Full Text] [Related]
19. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity.
Patil Y; Amitay Y; Ohana P; Shmeeda H; Gabizon A
J Control Release; 2016 Mar; 225():87-95. PubMed ID: 26809007
[TBL] [Abstract][Full Text] [Related]
20. Higher liposomal membrane fluidity enhances the in vitro antitumor activity of folate-targeted liposomal mitoxantrone.
Kawano K; Onose E; Hattori Y; Maitani Y
Mol Pharm; 2009; 6(1):98-104. PubMed ID: 19072653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
